Publication | Closed Access

MxA Gene Expression Analysis as an Interferon-β Bioactivity Measurement in Patients with Multiple Sclerosis and the Identification of Antibody-Mediated Decreased Bioactivity

ImmunodeficienciesImmune RegulationImmunologyPathologyImmune SystemImmune DysregulationInterferon-β Bioactivity MeasurementMolecular DiagnosticsNeuroimmunologyAutoimmune DiseaseAutoimmunityBrain-immune InteractionImmunologic DiseaseImmune FunctionAntibody-mediated Decreased BioactivityImmune Cell DevelopmentMultiple SclerosisMedicineImmunological Biomarkers